# Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease

> **NCT02750943** · NA · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 253 (actual)

## Conditions studied

- Gingivitis

## Interventions

- **DRUG:** Stannous Fluoride
- **DRUG:** Sodium Monofluorophosphate

## Key facts

- **NCT ID:** NCT02750943
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-01
- **Primary completion:** 2016-03-01
- **Final completion:** 2016-03-04
- **Target enrollment:** 253 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02750943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02750943, "Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02750943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*